Prosidyan entered into a joint collaboration and license agreement with MO-SCI to further development of boron-based bioactive glass material for use in spinal and trauma applications.
The technology was initially developed at the University of Missouri, and is protected by an intellectual property portfolio comprising 12 U.S. patents. Prosidyan seeks to create a new generation of bioactive glass products using Aeridyan, the trade name for the boron-based bioactive glass material.
Source: Prosidyan, Inc.
In 4Q15, Prosidyan received FDA 510(k) clearance to market FIBERGRAFT BG Morsels, an ultra-porous bone graft substitute comprising 45S5 Bioactive Glass microfibers and microspheres for use in posterolateral spinal fusion.
Prosidyan entered into a joint collaboration and license agreement with MO-SCI to further development of boron-based bioactive glass material for use in spinal and trauma applications.
The technology was initially developed at the University of Missouri, and is protected by an intellectual property portfolio comprising 12 U.S. patents....
Prosidyan entered into a joint collaboration and license agreement with MO-SCI to further development of boron-based bioactive glass material for use in spinal and trauma applications.
The technology was initially developed at the University of Missouri, and is protected by an intellectual property portfolio comprising 12 U.S. patents. Prosidyan seeks to create a new generation of bioactive glass products using Aeridyan, the trade name for the boron-based bioactive glass material.
Source: Prosidyan, Inc.
In 4Q15, Prosidyan received FDA 510(k) clearance to market FIBERGRAFT BG Morsels, an ultra-porous bone graft substitute comprising 45S5 Bioactive Glass microfibers and microspheres for use in posterolateral spinal fusion.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.